Get the Stockscreener App
1.01
0.98%
-0.01
Palisade Bio Inc stock is traded at $1.01, with a volume of 192.14K.
It is down -0.98% in the last 24 hours and up +41.24% over the past month.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
See More
Previous Close:
$1.02
Open:
$1.01
24h Volume:
192.14K
Relative Volume:
0.43
Market Cap:
$4.84M
Revenue:
-
Net Income/Loss:
$-14.07M
P/E Ratio:
-0.0722
EPS:
-13.99
Net Cash Flow:
$-12.56M
1W Performance:
-12.93%
1M Performance:
+41.24%
6M Performance:
-25.74%
1Y Performance:
-72.33%
1-Day Range:
$0.9851
$1.0796
1-Week Range:
$0.9546
$1.40
52-Week Range:
$0.60
$4.318
Palisade Bio Inc Stock (PALI) Company Profile
Name
Palisade Bio Inc
Sector
Industry
Phone
(858) 704-4900
Address
7750 EL CAMINO REAL, SUITE 5200, CARLSBAD
Compare PALI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PALI
Palisade Bio Inc
|
1.01 | 5.10M | 0 | -14.07M | -12.56M | -13.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Palisade Bio Inc Stock (PALI) Latest News
How sentiment analysis helps forecast Palisade Bio Inc.Buy and Hold Position Summary Review - Newser
What is the risk reward ratio of investing in Palisade Bio Inc. stockTop Growth Review With High Returns - jammulinksnews.com
What catalysts could drive Palisade Bio Inc. stock higher in 2025Top Growth Alerts For Smart Trading - jammulinksnews.com
When is Palisade Bio Inc. stock expected to show significant growthPost Market Target Finder For Every Investor - jammulinksnews.com
Intraday pattern recognizer results for Palisade Bio Inc.Free Real Market Momentum Signal Generator - Newser
How Palisade Bio Inc. stock performs during market volatilityFree AI-Powered Trade Planning with Indicators - Newser
Heatmap analysis for Palisade Bio Inc. and competitorsWeekly Stock Picks with Trend Confidence - Newser
Palisade Bio Receives Notice of Allowance for Composition - GlobeNewswire
What are Palisade Bio Inc. company’s key revenue driversLow Risk Updates For Beginners - jammulinksnews.com
Palisade Bio’s Phase 1 Study on PALI-2108: A New Hope for Ulcerative Colitis Treatment - MSN
Palisade Bio secures patent allowance in China for PALI-2108 By Investing.com - Investing.com Nigeria
Palisade Bio secures patent allowance in China for PALI-2108 - Investing.com
Novel IBD Drug Gets 20-Year China Patent Protection: $1B Market Opportunity for First-in-Class Treatment - Stock Titan
Institutional scanner results for Palisade Bio Inc.Quarterly Investment Outlook and Key Summary - Newser
When is the best time to buy Palisade Bio Inc. stockSecure Asset Flow and Trend Pattern Analysis - Newser
What makes Palisade Bio Inc. stock price move sharplyChart-Based Entry Confirmation for Beginners - Newser
Palisade Bio Inc. Enters Reversal Setup in Weekly ChartsStock Screener With Smart Filters Highlights Top Picks - metal.it
Palisade Bio Inc. Price Holds Above Key Fib LevelSwing Trading Plan With Smart Signals in Review - metal.it
Palisade Bio Inc. Sees Relief Buying After Extended DropBreakout Confirmation With Entry Tracker Enabled - metal.it
Is Palisade Bio Inc. a Top Dividend Stock to Watch in 2025Low Risk Trading Ideas - metal.it
How sentiment analysis helps forecast Palisade Bio Inc. Trend Analysis for Safer Market Entries - Newser
How does Palisade Bio Inc. compare to its industry peersExplosive earning power - jammulinksnews.com
Is Palisade Bio Inc. a growth stock or a value stockDiscover high-impact stocks for growth - jammulinksnews.com
What institutional investors are buying Palisade Bio Inc. stockAccelerated wealth building - jammulinksnews.com
What markets is Palisade Bio Inc. expanding into Is MLACU stock a good long term investment optionFree Predictions - jammulinksnews.com
Is Palisade Bio Inc. Stock a Good Fit for Conservative InvestorsFree Stock Investment Discussion Area - Newser
Should I hold or sell Palisade Bio Inc. stock in 2025Unlock hidden market opportunities today - jammulinksnews.com
Palisade Bio Inc. Stock Analysis and ForecastHigh-profit capital plays - PrintWeekIndia
What analysts say about Palisade Bio Inc. stockSkyrocketing investment returns - PrintWeekIndia
Palisade Bio Enters Warrant Inducement Agreement - TipRanks
What institutions are buying Palisade Bio Inc. stock nowFree Stock Selection - jammulinksnews.com
Palisade Bio Plunges 11.48% Despite Positive Trial Results - AInvest
What drives Palisade Bio Inc. stock priceBreakthrough financial growth - Autocar Professional
Palisade Bio Secures $3.9M Cash Injection: Strategic Warrant Exercise Deal Includes New 5-Year Warrants - Stock Titan
Palisade Bio Announces Exercise of Previously Issued Warrants for $3.9 Million - GlobeNewswire
Palisade Bio Skyrockets 16.28%—Can This Biotech Cinderella Story Sustain Its Magic? - AInvest
Is Palisade Bio Inc. a good long term investmentRecord-breaking gains - jammulinksnews.com
Palisade Bio Inc Stock (PALI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Palisade Bio Inc Stock (PALI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Wei Binxian | Director |
Nov 21 '24 |
Option Exercise |
0.00 |
388 |
0 |
855 |
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):